RiceBran Technologies (NASDAQ:RIBT), a global leader in the development and production of critical nutritional and functional ingredients derived from small and ancient grains for the healthy food, nutraceutical, pet care and animal feed markets, today announced financial results for the first quarter ended March 31, 2021.
Summary Results ($000s) | 1Q2021 | 1Q2020 | % Chg. | Qual | 1Q2021 | 4Q2020 | % Chg. | Qual | |
Revenue | $8,605 | $8,330 | +3% | Improved | $8,605 | $6,806 | +26% | Improved | |
Gross Profit (Loss) | $672 | $(405) | NM | Improved | $672 | $(47) | NM | Improved | |
Operating Income (Loss) | $(1,076) | $(2,955) | (64%) | Improved | $(1,076) | $(1,825) | (41%) | Improved | |
Net Income (Loss) | $591 | $(3,033) | NM | Improved | $591 | $(1,974) | NM | Improved | |
Adjusted EBITDA (Loss)* | $(159) | $(2,005) | (92%) | Improved | $(159) | $(932) | (83%) | Improved |
* Reconciliation of GAAP to Non-GAAP measures follows.
First Quarter 2021 Operating Highlights
"The first quarter's results demonstrate the initial success of shifting our focus to high value-add ingredients," said RiceBran's Executive Chairman Peter Bradley. "We are aligned with healthy living trends and believe there is a large unmet opportunity for our products across a wide range of applications. We are leaning into this opportunity with a revitalized sales team and plans to introduce new products and expand SRB and derivative production before year-end. These initiatives should support higher quarterly revenue growth, the transition to sustainable profitability, and generating significant returns for our shareholders."
First Quarter 2021 Financial Highlights
RiceBran's CFO Todd Mitchell commented, "The company's turnaround continues. Despite significant weather-related challenges, we delivered another quarter of improvement in quarter-over-quarter and year-over-year financial performance in key financial measures. Importantly, we were able to cut adjusted EBITDA losses (non-GAAP) to $159,000 and to generate neutral Cash Flows from Operations, driven by our first quarter of positive gross profits in nearly two years and a significant year-over-year reduction in SG&A. If this trend continues, we are well positioned to transition to positive adjusted EBITDA (non-GAAP) in 2021."
Full Year 2021 Outlook and Objectives
"We entered 2021 embarking on the second phase of our turnaround strategy, which will be focused on expanding our line-up of specialty ingredients, further enhancing our sales capabilities, expanding our supply partnerships, and strengthening our milling operations," Mr. Bradley added. "We firmly believe a significant unmet market opportunity exists for our high value-add SRB derivatives across a range of applications, led most immediately by demand in the health and wellness, and supplement, categories. Barring unforeseen circumstances, current trends point to the potential for sequential increases in revenue growth and gross profit, and a transition to positive adjusted EBITDA (non-GAAP) in 2021. This is just the beginning of a specialty ingredient expansion which will ultimately lead us to the introduction of products derived from other small and ancient grains."
Conference Call Information
RiceBran Technologies will host a conference call today, Wednesday, April 28, at 4:30 p.m. Eastern Time to discuss these results. The call information is as follows:
Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on April 28, 2021 until 11:59 p.m. EST on May 12, 2021 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 41066.
About RiceBran Technologies
RiceBran Technologies is a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. Notably, we are global leader in the production and marketing of stabilized rice bran (SRB), and high value-added derivative products derived from SRB, as well as a processor of rice, rice co-products, and barley and oat products. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. The target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers, both domestically and internationally. More information can be found in the Company's filings with the SEC and by visiting our website at http://www.ricebrantech.com.
Forward-Looking Statements
This release contains forward-looking statements, including, but not limited to, statements about RiceBran Technologies' expectations regarding its future financial results, sales growth, Adjusted EBITDA (non-GAAP) improvements, and SG&A. These statements are made based upon current expectations that are subject to known and unknown risks and uncertainties, including the risks that operations are disrupted by the COVID-19 pandemic and timing of profitable operations. RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies' filings with the Securities and Exchange Commission, including its most recent periodic reports.
Use of Non-GAAP Financial Information
We utilize "Adjusted EBITDA" "Net Cash" and "Net Debt" as supplemental measures in our ongoing analysis of short term and long-term cash requirement and liquidity needs. Management uses Adjusted EBITDA as an indicator of our current financial performance. By eliminating the impact of all material non-cash charges as well as items that do not regularly occur, we believe that Adjusted EBITDA provides a more accurate and informative indicator of our cash requirements. Adjusted EBITDA does not represent cash flows from operations as defined by generally accepted accounting principles ("GAAP"), is not a measure derived in accordance with GAAP and should not be considered as an alternative to net income (the most comparable GAAP financial measure to Adjusted EBITDA).
The tables below contain a reconciliation of net loss (GAAP) and Adjusted EBITDA (Non-GAAP) for the three months ended March 31, 2021 and March 31, 2020, and for Net Cash (non-GAAP) and Net Debt (non-GAAP) for the periods ended March 31, 2021 and December 31, 2020. We do not provide a reconciliation of forward-looking net loss (GAAP) to Adjusted EBITDA (Non-GAAP). Due to the nature of certain reconciling items, it is not possible to predict with any reliability what future outcomes may be with regard to the expense or income that may ultimately be recognized in future periods. Any forward-looking Adjusted EBITDA information that we may provide from time to time consistently excludes the same items from projected net loss that are excluded from actual net loss in the table below.
Investor Contact
Rob Fink / Matt Chesler, CFA
FNK IR
This email address is being protected from spambots. You need JavaScript enabled to view it.
646.809.4048 / 646.809.2183
RiceBran Technologies
Consolidated Income Statement (GAAP)
(in $000, except per share amounts)
3 Months Ended | ||||||||||
3/31/21 | 3/31/20 | % Chg. | ||||||||
Revenue | $8,605 | $8,330 | 3% | |||||||
Cost of Goods Sold | (7,933) | (8,735) | (9%) | |||||||
Gross Profit (Loss) | 672 | (405) | NM | |||||||
Gross Margin | 8% | (5%) | ||||||||
Selling, General & Admin. | (1,741) | (2,550) | (32%) | |||||||
Loss on PP&E | (7) | - | NM | |||||||
Operating Loss | (1,076) | (2,955) | (64%) | |||||||
Interest Expense | (111) | (38) | 192% | |||||||
Gain on extinguishment of PPP debt | 1,792 | - | NM | |||||||
Other Expense | (13) | (40) | (68%) | |||||||
Income (Loss) Before Income Taxes | 592 | (3,033) | NM | |||||||
Income Tax Benefit | (1) | - | NM | |||||||
Net Income (Loss) | 591 | (3,033) | NM | |||||||
Basic & Diluted Earnings (Loss) per Share: | $0.01 | ($0.08) | NM | |||||||
Weighted Average Shares Outstanding: | ||||||||||
Basic | 45,635 | 39,963 | 14% | |||||||
Diluted | 46,556 | 39,963 | 16% | |||||||
RiceBran Technologies
EBITDA and Adjusted EBITDA Reconciliation (Unaudited) (Non-GAAP)
(in $000)
3 Months Ended | ||||||||||
3/31/21 | 3/31/20 | % Chg. | ||||||||
Net Income (Loss) | $591 | ($3,033) | NM | |||||||
Gain on PPP debt (exclusion) | (1,792) | - | NM | |||||||
Interest Expense | 111 | 38 | 192% | |||||||
Depreciation and Amortization | 665 | 638 | 4% | |||||||
EBITDA | (425) | (2,357) | (82%) | |||||||
Other Expense | 13 | 40 | NM | |||||||
Share Based Comp | 253 | 312 | (19%) | |||||||
Adjusted EBITDA | ($159) | ($2,005) | (92%) | |||||||
RiceBran Technologies
Consolidated Statement of Cash Flows
(in $000)
3 Months Ended | ||||||||||
3/31/21 | 3/31/20 | |||||||||
Cash Flow from Operations | ||||||||||
Net Income (Loss) | $591 | ($3,033) | ||||||||
Adjustments to reconcile net income (loss) to net | ||||||||||
cash used in operating activities: | ||||||||||
Depreciation | 612 | 579 | ||||||||
Amortization | 53 | 59 | ||||||||
Share-Based Compensation | 253 | 312 | ||||||||
Gain on extinguishment of PPP debt | (1,792) | - | ||||||||
Other | (18) | (79) | ||||||||
Changes in operating assets and liabilities | ||||||||||
Accounts Receivable | (808) | (1,315) | ||||||||
Inventories | 384 | (1,018) | ||||||||
Accounts Payable | 508 | 231 | ||||||||
Commodities Payable | 556 | 1,108 | ||||||||
Other | (340) | (178) | ||||||||
Net Cash Flow from Operations | ($1) | ($3,334) | ||||||||
Cash Flow from Investing | ||||||||||
Purchases of property and equipment | (325) | (221) | ||||||||
Net Cash Flow from Investing | ($325) | ($221) | ||||||||
Cash Flow from Financing | ||||||||||
Net Change in Debt | 481 | 628 | ||||||||
Net Cash Flow from Financing | $481 | $628 | ||||||||
Net Change in Cash | $155 | ($2,927) | ||||||||
BOP Cash Balance | 5,263 | 8,444 | ||||||||
Net Change in Cash | 155 | (2,927) | ||||||||
EOP Cash Balance | $5,418 | $5,517 | ||||||||
RiceBran Technologies
Consolidated Balance Sheets
(in $000)
Period Ended | ||||||||||
3/31/21 | 12/31/20 | |||||||||
Assets | ||||||||||
Cash and Cash Equivalents | $5,418 | $5,263 | ||||||||
Accounts Receivable, net | 3,627 | 2,819 | ||||||||
Inventories | 1,494 | 1,878 | ||||||||
Other Current Assets | 1,722 | 1,380 | ||||||||
Total Current Assets | 12,261 | 11,340 | ||||||||
PP&E, Net | 15,860 | 16,367 | ||||||||
Operating Lease right-of-use assets | 2,372 | 2,452 | ||||||||
Goodwill & Intangibles | 4,585 | 4,637 | ||||||||
Total Assets | $35,078 | $34,796 | ||||||||
Liabilities and Shareholders' Equity | ||||||||||
Accounts Payable | $1,076 | $955 | ||||||||
Commodities Payable | 1,381 | 825 | ||||||||
Accruals | 1,273 | 1,137 | ||||||||
Leases, Current | 442 | 426 | ||||||||
Debt, Current | 3,178 | 2,483 | ||||||||
Total Current Liabilities | 7,350 | 5,826 | ||||||||
Leases, Not Current | 2,313 | 2,443 | ||||||||
Debt, Not Current | 1,154 | 3,107 | ||||||||
Total Liabilities | $10,817 | $11,376 | ||||||||
Preferred Stock | 112 | 112 | ||||||||
Common Stock | 322,468 | 322,218 | ||||||||
Accumulated Deficit | (298,319) | (298,910) | ||||||||
Total Shareholders' Equity | 24,261 | 23,420 | ||||||||
Total Liabilities and Shareholders' Equity | $35,078 | $34,796 |
RiceBran Technologies
Net-Cash and Net Debt Reconciliation (Unaudited) (Non-GAAP)
(in $000)
Period Ended | |||||||||
3/31/21 | 12/31/20 | ||||||||
Cash and Cash Equivalents | $5,418 | $5,263 | |||||||
Less: Total Debt, Current and Non-current | 4,332 | 5,590 | |||||||
Net Cash (Debt) | $1,086 | ($327) |
Last Trade: | US$0.16 |
Daily Change: | -0.19 -52.89 |
Daily Volume: | 2,788 |
Market Cap: | US$1.650M |
December 20, 2023 August 21, 2023 June 13, 2023 March 16, 2023 |
DevvStream provides upfront capital for sustainability projects in exchange for carbon credit rights. Through these rights, the company generates and manages carbon credits by utilizing the most technologically advanced...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS